Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
Konstantinos Tziomalos 1, Vasilios G Athyros 2, Asterios Karagiannis 2, Dimitri P Mikhailidis 1, *
Identifiers and Pagination:Year: 2011
First Page: 85
Last Page: 89
Publisher ID: TOCMJ-5-85
Article History:Received Date: 30/11/2010
Revision Received Date: 4/1/2011
Acceptance Date: 6/1/2011
Electronic publication date: 24/2/2011
Collection year: 2011
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Dyslipidemia is a major vascular risk factor. Interestingly, several agents used for the prevention and treatment of vascular diseases have an adverse effect on the lipid profile. In addition, agents belonging to the same class (e.g. beta blockers) can have significantly different actions on lipid levels. We summarize the effects of drugs used for the prevention and treatment of vascular diseases on the lipid profile. These effects should be considered when selecting a specific agent, particularly in high-risk patients.